[Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy* / Q000209:etiology; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use; D013806:Theophylline / Q000031:analogs & derivatives*; D014971:Xanthinol Niacinate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014971:Xanthinol Niacinate; D013806:Theophylline; D010431:Pentoxifylline
Los derivados xantínicos en el tratamiento del síndrome de claudicación intermitente en pacientes diabéticos.